Safety and Early Outcomes Using a Corticosteroid-Avoidance Immunosuppression Protocol in Pediatric Heart Transplant Recipients

Journal of Heart and Lung Transplantation - Netherlands
doi 10.1016/j.healun.2009.11.601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunosuppression in Pediatric Liver Transplant Recipients: Unique Aspects

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Cardiovascular Outcomes in Heart Transplant Recipients

Journal of Nuclear Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2019English

Emergency Department Utilization by Pediatric Heart Transplant Recipients

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Everolimus-Based Immunosuppression in Liver Transplant Recipients

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Renal Recovery After Conversion to an Everolimus-Based Immunosuppression in Early and Late Heart Transplant Recipients: A 12-Month Analysis

Experimental and Clinical Transplantation
Transplantation
2013English

Hyperuricemia in Pediatric Renal Transplant Recipients

Experimental and Clinical Transplantation
Transplantation
2013English

Clinical Predictors of Autoimmune and Severe Atopic Disease in Pediatric Heart Transplant Recipients

Pediatric Transplantation
Child HealthTransplantationPediatricsPerinatology
2013English

Safety Events in Kidney Transplant Recipients

Transplantation
Transplantation
2015English

Late Graft Failure in Heart Transplant Recipients: Incidence, Risk Factors and Clinical Outcomes

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy